Streetbeat News

Revenues

BAC

JPM

WFC

The major U.S. banks JPMorgan Chase, Wells Fargo, Bank of America, and Citigroup reported their Q4 2023 earnings with mixed results due to one-time charges. Bank of America's profit fell short of expectations, while Wells Fargo saw a rise in credit loss provisions and warned of a net interest income drop. JPMorgan Chase reported its best ever annual profit, and Citigroup reported its worst quarter in 14 years but is optimistic about 2024 after restructuring.

Portfolio Pulse from Upwallstreet

January 12, 2024 | 8:42 pm

NFLX

Oppenheimer analyst Jason Helfstein upgraded Netflix Inc's (NASDAQ:NFLX) price target from $475 to $600, a 26% increase, due to surging ad Monthly Active Users (MAUs). MAUs have grown to over 23 million, up from 15 million in November and 5 million in May. This growth suggests higher than expected 4Q net adds and potential for continued subscriber growth into 2024. Helfstein raised his 4Q and FY24 net adds estimates and increased revenue and EBITDA forecasts for FY24 and FY25. He also introduced FY26 estimates and maintained an Outperform rating for NFLX.

Portfolio Pulse from Anusuya Lahiri

January 12, 2024 | 8:31 pm

MDT

Medtronic (NYSE:MDT) has received mixed ratings from 4 analysts in the past three months, with an average 12-month price target of $89.75, slightly down from the previous $90.00. Analysts' actions include both upgrades and downgrades, reflecting varied perspectives on the company's performance. Medtronic is a major medical-device company with a strong market presence, but it faces challenges in revenue growth, ROE, and ROA compared to industry averages, while its net margin and debt management are positive indicators.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 8:01 pm

ZBH

Zimmer Biomet Holdings (NYSE:ZBH) has received mixed analyst ratings over the last quarter, with 10 analysts offering varied sentiments. The recent ratings show 4 somewhat bullish and 6 indifferent, with no bullish or bearish ratings. The 12-month price target average for ZBH is now $128.8, down from $138.11, indicating a 6.74% decrease. Analysts from firms like RBC Capital, Evercore ISI Group, and Morgan Stanley have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. Zimmer Biomet, a leader in orthopedic reconstructive implants, has shown a revenue growth rate of 5.02% as of September 30, 2023, but trails behind industry peers and shows lower profitability and return metrics compared to industry averages.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 8:00 pm

RHP

Analysts have provided varying ratings for Ryman Hospitality Props (NYSE:RHP) over the last quarter, with a recent shift towards a more bullish stance. The average 12-month price target for RHP has increased to $116.0, up from $107.20, with a high estimate of $134.00 and a low of $102.00. Analysts from Truist Securities, Wells Fargo, and JP Morgan have raised their price targets, reflecting positive market dynamics and company performance. Ryman Hospitality Props is a REIT specializing in upscale convention center resorts and country music entertainment, with strong financial indicators such as a 12.99% revenue growth rate and a net margin of 7.8%.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 8:00 pm

SYK

Stryker (NYSE:SYK) has received mixed analyst ratings over the past three months, with 7 analysts offering views ranging from bullish to indifferent. The average 12-month price target for SYK has increased by 10.1% to $324.57, with a high estimate of $345.00 and a low of $297.00. Analysts from RBC Capital, Truist Securities, Morgan Stanley, Roth MKM, and UBS have adjusted their ratings and price targets, reflecting a positive outlook on the company's performance. Stryker is a major player in medical equipment and has shown strong financial indicators such as a 9.6% revenue growth rate, a net margin of 14.1%, and an ROA of 1.83%, but a lower-than-average ROE of 3.92% and a conservative debt-to-equity ratio of 0.71.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 8:00 pm

NDAQ

Analysts have provided mixed reviews on Nasdaq (NASDAQ:NDAQ) over the last three months, with 6 analysts offering ratings ranging from bullish to indifferent. The average 12-month price target is $64.33, with a recent increase from $57.33. Analysts from Citigroup, Goldman Sachs, JP Morgan, Morgan Stanley, Oppenheimer, and Rosenblatt have updated their ratings and price targets. Nasdaq faces challenges with a revenue decline of -6.81%, a below-average net margin, and a high debt-to-equity ratio, but it has a strong ROE.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 8:00 pm

AAL

AZO

DAL

KIE

LOW

PLOW

UAL

A major winter storm in the Midwest is expected to impact various sectors, with potential benefits for retailers like Home Depot and Lowe's, and AutoZone due to increased sales of winter essentials. Douglas Dynamics may gain if the winter is harsh, as it manufactures snow plows and salt spreaders. Insurers could face high claims, affecting the SPDR S&P Insurance ETF. Airlines are experiencing delays and cancellations, with negative sentiment impacting stocks like United, Delta, and American Airlines.

Portfolio Pulse from Neil Dennis

January 12, 2024 | 7:54 pm

GTBIF

IWM

MSOS

QQQ

SPY

VRNOF

Virginia lawmakers have filed legislation to legalize marijuana sales, despite the governor's lack of interest. New Jersey is considering over a dozen cannabis policy bills, while Arizona's cannabis market shows stability. The U.S. cannabis ETF MSOS showed resilience despite market volatility, and there's anticipation for a DEA headline regarding marijuana rescheduling. Putnam Global Health Care Fund made notable stock moves in the cannabis sector, and Illinois reported an increase in adult-use cannabis sales. Analysts predict significant financial benefits if the 280E tax is removed for U.S. cannabis companies.

Portfolio Pulse from Todd Harrison

January 12, 2024 | 7:47 pm

UNP

Union Pacific has announced that customers with shipments moving through states affected by operational disruptions should expect delays until the company can restore operations.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 7:11 pm